BlackRock Fund Advisors’s HI-TECH PHARMACAL INC HITK Stock Holding History

BlackRock Fund Advisors’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-788,097	Closed	-$34.1M	–	3974
2014 Q1	$34.1M	Buy	788,097 +5,135	+0.7%	+$223K	0.01%	1673
2013 Q4	$34M	Buy	782,962 +17,449	+2%	+$754K	0.01%	1655
2013 Q3	$33M	Buy	765,513 +71,230	+10%	+$2.73M	0.01%	1630
2013 Q2	$23.1M	Buy	+694,283	New	+$23.1M	0.01%	1755

BlackRock Fund Advisors's HITK Position: Q2 2014 in Review

BlackRock Fund Advisors sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 788,097 shares — an estimated $34.1M sold.

BlackRock Fund Advisors first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $34.1M in Q1 2014. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

BlackRock Fund Advisors reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
BlackRock Fund Advisors sold 788,097 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $34.1M.
BlackRock Fund Advisors first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
BlackRock Fund Advisors's HI-TECH PHARMACAL INC position peaked at $34.1M in Q1 2014.
0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on BlackRock Fund Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.